Difloxacin
Alternative Names: A 56619Latest Information Update: 23 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Antibacterials; Quinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 27 Nov 1994 Discontinued-II for Bacterial infections in USA (PO)